- Home
- ETON vs PETS Comparison
ETON vs PETS Comparison
Compare ETON & PETS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ETON | PETS |
|---|---|---|
| Founded | 2017 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Retail-Drug Stores and Proprietary Stores |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 498.8M | 63.7M |
| IPO Year | 2018 | N/A |
Fundamental Metrics
Financial Performance| Metric | ETON | PETS |
|---|---|---|
| Price | $16.67 | $3.42 |
| Analyst Decision | Strong Buy | Sell |
| Analyst Count | 3 | 1 |
| Target Price | ★ $29.67 | $3.20 |
| AVG Volume (30 Days) | 262.5K | ★ 7.7M |
| Earning Date | 11-06-2025 | 02-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $70,316,000.00 | ★ $198,265,000.00 |
| Revenue This Year | $113.27 | N/A |
| Revenue Next Year | $36.70 | $2.98 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 102.77 | N/A |
| 52 Week Low | $11.09 | $1.57 |
| 52 Week High | $23.00 | $5.58 |
Technical Indicators
Market Signals| Indicator | ETON | PETS |
|---|---|---|
| Relative Strength Index (RSI) | 51.08 | 66.75 |
| Support Level | $15.75 | $1.69 |
| Resistance Level | $16.95 | $3.89 |
| Average True Range (ATR) | 0.64 | 0.39 |
| MACD | 0.11 | 0.16 |
| Stochastic Oscillator | 63.89 | 72.73 |
Price Performance
Historical ComparisonAbout ETON Eton Pharmaceuticals Inc.
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of hereditary tyrosinemia type 1 (HT-1). The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector.
About PETS PetMed Express Inc.
PetMed Express Inc along with its subsidiaries is a nationwide pet pharmacy. The company markets prescription and non-prescription pet medications, health products, and supplies for dogs and cats, direct to the consumer. The company generates its revenue by selling pet medications and pet supplies mainly to retail consumers.